Innovation Grant Awarded for Qu Biologics Project with University of Ottawa Scientist
April 04, 2017 15:15 ET
|
Qu Biologics
VANCOUVER, British Columbia, April 04, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies...